Cleared Traditional

K170299 - Ion PGM Dx System

K170299 is an FDA 510(k) clearance for Ion PGM Dx System, manufactured by Life Technologies Corporation. The device is a Class 2 Chemistry device with product code PFF cleared through the Traditional 510(k) pathway after a 142-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2017
Decision
142d
Days
Class 2
Risk

K170299 is an FDA 510(k) clearance for the Ion PGM Dx System. Classified as High Throughput Dna Sequence Analyzer (product code PFF), Class II - Special Controls.

Submitted by Life Technologies Corporation (Carlsbad, US). The FDA issued a Cleared decision on June 22, 2017 after a review of 142 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.2265 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Life Technologies Corporation devices

FDA 510(k) Submission Details - K170299

510(k) Number K170299 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 31, 2017
Decision Date June 22, 2017
Days to Decision 142 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
54d slower than avg
Panel avg: 88d · This submission: 142d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

PFF Device Classification - Class 2, Special Controls

Product Code PFF High Throughput Dna Sequence Analyzer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.2265
Definition A High Throughput Sequencing Technology Performing Targeted Dna Sequencing Of Amplicons From A Defined Genetic Region Or A Subset Of Genes In Human Genomic Dna From A Clinical Sample.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.